NeuroOne Medical Technologies Corporation (NMTC)
Automate Your Wheel Strategy on NMTC
With Tiblio's Option Bot, you can configure your own wheel strategy including NMTC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NMTC
- Rev/Share 0.1851
- Book/Share 0.0362
- PB 16.2763
- Debt/Equity 0.2766
- CurrentRatio 2.129
- ROIC -2.3517
- MktCap 29342684.0
- FreeCF/Share -0.1593
- PFCF -5.9222
- PE -2.7751
- Debt/Assets 0.0699
- DivYield 0
- ROE -3.3457
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | NMTC | Ladenburg Thalmann | -- | Buy | -- | $1.45 | May 5, 2025 |
News
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
Published: June 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced it has strengthened its management team with the appointment of Emily Johns as General Counsel and Corporate Secretary.
Read More
NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025
Published: May 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
EDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its participation in the MedInvest MedTech, AI and Digital Health Conference taking place in San Francisco, CA on June 3-4, 2025.
Read More
NeuroOne Medical Technologies Corporation (NMTC) Q2 2025 Earnings Call Transcript
Published: May 13, 2025 by: Seeking Alpha
Sentiment: Neutral
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Dave Rosa – CEO Ron McClurg – CFO Chris Volker - COO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Good day, ladies and gentlemen. Welcome to the Second Quarter of Fiscal Year 2025 Financial Results Conference Call for NeuroOne Medical Technologies Corporation.
Read More
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor
Published: May 12, 2025 by: GlobeNewsWire
Sentiment: Neutral
Significant Neurological Expertise to Help Drive Clinical Development Strategy and Growth with New Technologies
Read More
NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time
Published: May 01, 2025 by: GlobeNewsWire
Sentiment: Neutral
EDEN PRAIRIE, Minn., May 01, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal second quarter ended March 31, 2025, before market open on May 13, 2025.
Read More
NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock
Published: April 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today the pricing of an underwritten registered public offering of 16,000,000 shares of its common stock at a price of $0.50 per share.
Read More
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace
Published: March 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that CEO Dave Rosa was featured on Today's Marketplace (TMP) alongside Dr. Jessica Clark, DNP, RN, Dean of the College of Nursing at Creighton University.
Read More
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Published: March 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced that it will participate in the upcoming Oppenheimer 35th Annual Healthcare Conference MedTech & Services Conference on Wednesday, March 19, 2025.
Read More
NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
Published: February 12, 2025 by: GlobeNewsWire
Sentiment: Neutral
Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenue from Zimmer Biomet EDEN PRAIRIE, Minn., Feb. 12, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, has reported financial results for the first quarter fiscal year 2025 ended December 31, 2024.
Read More
About NeuroOne Medical Technologies Corporation (NMTC)
- IPO Date 2018-03-15
- Website https://n1mtc.com
- Industry Medical - Devices
- CEO Mr. David A. Rosa M.D.
- Employees 17